Education
About Us
Working with TipRanks
Follow Us
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
:SHPH
RESEARCH TOOLSreports
SHPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.00 - $92.04
Previous CloseN/A
Volume45.16K
Average Volume (3M)242.88K
Market Cap
$4.25M
Enterprise Value$1.62M
Total Cash (Recent Filing)$4.51M
Total Debt (Recent Filing)$1.10M
Price to Earnings (P/E)―
Beta0.46
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.25
Shares Outstanding1,070,325
10 Day Avg. Volume288,779
30 Day Avg. Volume242,877
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)12.51
Price to Sales (P/S)0.00
P/FCF Ratio-0.51
Enterprise Value/Market Cap0.38
Enterprise Value/Revenue52.65
Enterprise Value/Gross Profit-1.69K
Enterprise Value/Ebitda-0.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shuttle Pharmaceuticals Holdings, Inc. News
PremiumCompany Announcements
Shuttle Pharmaceuticals Secures $4.25M in Private Placement
PremiumCompany Announcements
Shuttle Pharmaceuticals Announces Major Salary Reductions
PremiumCompany Announcements
Shuttle Pharmaceuticals Announces Leadership Changes and Meeting OutcomesOptions Prices
Currently, No data available
---
Ownership Overview
12.68% Insiders
1.02% Mutual Funds
0.84% Other Institutional Investors
86.30% Public Companies and
Individual Investors
SHPH FAQ
What was Shuttle Pharmaceuticals Holdings, Inc.’s price range in the past 12 months?
Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $3.00 and its highest was $92.04 in the past 12 months.
What is Shuttle Pharmaceuticals Holdings, Inc.’s market cap?
Shuttle Pharmaceuticals Holdings, Inc.’s market cap is $4.25M.
When is Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Shuttle Pharmaceuticals Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is Shuttle Pharmaceuticals Holdings, Inc. overvalued?
According to Wall Street analysts Shuttle Pharmaceuticals Holdings, Inc.’s price is currently Overvalued.
Does Shuttle Pharmaceuticals Holdings, Inc. pay dividends?
Shuttle Pharmaceuticals Holdings, Inc. does not currently pay dividends.
What is Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate?
Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shuttle Pharmaceuticals Holdings, Inc. have?
Shuttle Pharmaceuticals Holdings, Inc. has 1,070,325 shares outstanding.
What happened to Shuttle Pharmaceuticals Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Shuttle Pharmaceuticals Holdings, Inc.?
Currently, no hedge funds are holding shares in SHPH
Company Description
Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Technical Analysis
Alaunos Therapeutics
―
Scinai Immunotherapeutics
―
InMed Pharmaceuticals
―
Hyperion DeFi
―
Revelation Biosciences
―